← Curtiss-Wright overview

Curtiss-Wright vs China National Nuclear Power: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Curtiss-Wright Corporation (CW)

Q3 2026
▲3▼1

Curtiss-Wright's Strong Q2 and Nuclear Growth Offset Valuation Concerns

  • Q2 Earnings Beat and Guidance Raise Curtiss-Wright reported Q2 sales up 5% to $924 million, operating income up 12%, and free cash flow up 37% to $160 million. Management raised full-year guidance, signaling confidence in continued growth. This positive news supports a higher stock price as it reflects strong execution and future earnings potential.

    This is the most recent and significant event, directly impacting CW's valuation and investor sentiment.

  • Nuclear Expansion and DOE Loan Commitment Curtiss-Wright expects an AP1000 reactor order by year-end, backed by a conditional $17.5 billion DOE loan for up to 10 reactors. The company aims to quadruple commercial nuclear revenues to $1.5 billion by mid-next decade. This long-term growth driver adds significant upside potential, boosting investor optimism.

    This highlights a major growth avenue that could substantially increase future revenues, a key factor for long-term investors.

  • Valuation Risk and Stock Pullback Despite strong results, CW's stock fell 8% after earnings and trades at $688.63. Its P/E of 47.7x is above the industry average of 39.9x, suggesting overvaluation. If sentiment cools, the stock could face further downside, as investors may question the high multiple relative to peers.

    This counterweight explains why the stock dropped despite good news and highlights a key risk for investors.

  • Record Defense Spending and Strong Backlog Global military spending hit a record $2.9 trillion in 2025, and CW's new orders rose 16% to a $4.3 billion backlog, with 90% expected to convert to revenue within three years. This robust demand environment supports future revenue growth and earnings stability.

    This underscores the strong demand backdrop that underpins CW's growth trajectory, a fundamental driver.

July 2026
▲3▼1

Curtiss-Wright's Strong Q2 and Nuclear Growth Offset Valuation Concerns

  • Q2 Earnings Beat and Guidance Raise Curtiss-Wright reported Q2 sales up 5% to $924 million, operating income up 12%, and free cash flow up 37% to $160 million. Management raised full-year guidance, signaling confidence in continued growth. This positive news supports a higher stock price as it reflects strong execution and future earnings potential.

    This is the most recent and significant event, directly impacting CW's valuation and investor sentiment.

  • Nuclear Expansion and DOE Loan Commitment Curtiss-Wright expects an AP1000 reactor order by year-end, backed by a conditional $17.5 billion DOE loan for up to 10 reactors. The company aims to quadruple commercial nuclear revenues to $1.5 billion by mid-next decade. This long-term growth driver adds significant upside potential, boosting investor optimism.

    This highlights a major growth avenue that could substantially increase future revenues, a key factor for long-term investors.

  • Valuation Risk and Stock Pullback Despite strong results, CW's stock fell 8% after earnings and trades at $688.63. Its P/E of 47.7x is above the industry average of 39.9x, suggesting overvaluation. If sentiment cools, the stock could face further downside, as investors may question the high multiple relative to peers.

    This counterweight explains why the stock dropped despite good news and highlights a key risk for investors.

  • Record Defense Spending and Strong Backlog Global military spending hit a record $2.9 trillion in 2025, and CW's new orders rose 16% to a $4.3 billion backlog, with 90% expected to convert to revenue within three years. This robust demand environment supports future revenue growth and earnings stability.

    This underscores the strong demand backdrop that underpins CW's growth trajectory, a fundamental driver.

Latest
▲3▼1

Curtiss-Wright's Strong Q2 and Nuclear Growth Offset Valuation Concerns

  • Q2 Earnings Beat and Guidance Raise Curtiss-Wright reported Q2 sales up 5% to $924 million, operating income up 12%, and free cash flow up 37% to $160 million. Management raised full-year guidance, signaling confidence in continued growth. This positive news supports a higher stock price as it reflects strong execution and future earnings potential.

    This is the most recent and significant event, directly impacting CW's valuation and investor sentiment.

  • Nuclear Expansion and DOE Loan Commitment Curtiss-Wright expects an AP1000 reactor order by year-end, backed by a conditional $17.5 billion DOE loan for up to 10 reactors. The company aims to quadruple commercial nuclear revenues to $1.5 billion by mid-next decade. This long-term growth driver adds significant upside potential, boosting investor optimism.

    This highlights a major growth avenue that could substantially increase future revenues, a key factor for long-term investors.

  • Valuation Risk and Stock Pullback Despite strong results, CW's stock fell 8% after earnings and trades at $688.63. Its P/E of 47.7x is above the industry average of 39.9x, suggesting overvaluation. If sentiment cools, the stock could face further downside, as investors may question the high multiple relative to peers.

    This counterweight explains why the stock dropped despite good news and highlights a key risk for investors.

  • Record Defense Spending and Strong Backlog Global military spending hit a record $2.9 trillion in 2025, and CW's new orders rose 16% to a $4.3 billion backlog, with 90% expected to convert to revenue within three years. This robust demand environment supports future revenue growth and earnings stability.

    This underscores the strong demand backdrop that underpins CW's growth trajectory, a fundamental driver.

China National Nuclear Power (601985.CG)

Q3 2026
▲3▼1

New nuclear approvals lift pipeline, but first-half profit drops sharply

  • Four new nuclear units approved for China National Nuclear Power The State Council approved Liaoning Zhuanghe Units 1-2 and Zhejiang Jinqimen Units 3-4, both using Hualong One reactors. More approved units mean a bigger long-term project pipeline and future earnings for the company.

    This is the main new positive force expanding the company's growth pipeline.

  • 10.3 billion yuan procurement for high-temperature reactor project A subsidiary plans to buy contracting services for the Jiangsu Xuwei nuclear heating and power plant's high-temperature reactor phase one. The large order shows the project is moving forward, which supports future revenue for the parent.

    It shows concrete project progress that can add future revenue.

  • First-half profit fell 35.74% on weaker revenue Net profit dropped to 3.641 billion yuan and revenue fell 6.28%. Second-quarter profit also slipped versus the first quarter. Weaker earnings weigh on the stock because investors pay for current profits, not just future projects.

    This is the main new negative force and a real counterweight to the approval news.

  • 170 billion yuan of nuclear investment approved nationwide The four approved projects total eight units and over 170 billion yuan of investment, the first batch under the 15th Five-Year Plan. This signals strong state support for nuclear power, helping the whole sector including this company.

    It shows the policy backdrop that supports the company's long-term growth.

August 2026
▲3▼1

New nuclear approvals lift pipeline, but first-half profit drops sharply

  • Four new nuclear units approved for China National Nuclear Power The State Council approved Liaoning Zhuanghe Units 1-2 and Zhejiang Jinqimen Units 3-4, both using Hualong One reactors. More approved units mean a bigger long-term project pipeline and future earnings for the company.

    This is the main new positive force expanding the company's growth pipeline.

  • 10.3 billion yuan procurement for high-temperature reactor project A subsidiary plans to buy contracting services for the Jiangsu Xuwei nuclear heating and power plant's high-temperature reactor phase one. The large order shows the project is moving forward, which supports future revenue for the parent.

    It shows concrete project progress that can add future revenue.

  • First-half profit fell 35.74% on weaker revenue Net profit dropped to 3.641 billion yuan and revenue fell 6.28%. Second-quarter profit also slipped versus the first quarter. Weaker earnings weigh on the stock because investors pay for current profits, not just future projects.

    This is the main new negative force and a real counterweight to the approval news.

  • 170 billion yuan of nuclear investment approved nationwide The four approved projects total eight units and over 170 billion yuan of investment, the first batch under the 15th Five-Year Plan. This signals strong state support for nuclear power, helping the whole sector including this company.

    It shows the policy backdrop that supports the company's long-term growth.

Latest
▲3▼1

New nuclear approvals lift pipeline, but first-half profit drops sharply

  • Four new nuclear units approved for China National Nuclear Power The State Council approved Liaoning Zhuanghe Units 1-2 and Zhejiang Jinqimen Units 3-4, both using Hualong One reactors. More approved units mean a bigger long-term project pipeline and future earnings for the company.

    This is the main new positive force expanding the company's growth pipeline.

  • 10.3 billion yuan procurement for high-temperature reactor project A subsidiary plans to buy contracting services for the Jiangsu Xuwei nuclear heating and power plant's high-temperature reactor phase one. The large order shows the project is moving forward, which supports future revenue for the parent.

    It shows concrete project progress that can add future revenue.

  • First-half profit fell 35.74% on weaker revenue Net profit dropped to 3.641 billion yuan and revenue fell 6.28%. Second-quarter profit also slipped versus the first quarter. Weaker earnings weigh on the stock because investors pay for current profits, not just future projects.

    This is the main new negative force and a real counterweight to the approval news.

  • 170 billion yuan of nuclear investment approved nationwide The four approved projects total eight units and over 170 billion yuan of investment, the first batch under the 15th Five-Year Plan. This signals strong state support for nuclear power, helping the whole sector including this company.

    It shows the policy backdrop that supports the company's long-term growth.

© 2026 MarketIVWhy